Peptiverse OÜ

Active Registry code 16935158 OÜ Tallinn Registered 5 Mar 2024
Compare

Peptiverse OÜ is a OÜ based in Tallinn, registry code 16935158, status: active. Main activity: Research and experimental development on biotechnology. There is no EMTA tax data for this company on the site.

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2024 – 2025
Net profit, € 2025: 0 € · industry median 0 € · above 40% of the industry
0.00.00.00.00.00.02024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250.00.00.00.00.00.02024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 100 € · +0.0% vs 2024
0204060801002024 Company: 100 €20242025 Company: 100 €20250204060801002024 Company: 100 €2025 Company: 100 €2025
Equity, € 2025: 100 € · +0.0% vs 2024
0204060801002024 Company: 100 €20242025 Company: 100 €20250204060801002024 Company: 100 €2025 Company: 100 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.20.40.60.81.02024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.20.40.60.81.02024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — 0 0 100 100 0
2024 — 0 0 100 100 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
0.0 %
Net profit / equity
Return on assets (ROA)
0.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 21 Apr 2026 Company’s own e-Äriregister
2024 5 Mar 2024 – 31 Dec 2024 23 Mar 2025 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main

Rulings 1

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50249683
5 Mar 2024
 First entry In force
5 Mar 2024
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data